Literature DB >> 3557187

Is there a relationship between symptoms of the irritable bowel syndrome and objective measurements of large bowel function? A longitudinal study.

G J Oettlé, K W Heaton.   

Abstract

Four patients with the irritable bowel syndrome completed 28 day continuous stool collections and concurrent symptom diaries. The diaries revealed that three patients had multiple pains. When the diaries were compared with objective measurements, no relationship could be detected between the occurrence of pain or any other symptom on the one hand and stool weight, stool form or consistency, mean whole gut transit time, or interdefecatory transit on the other. Patients' descriptions of urgency, looseness and frequency of defecation give little guide to intestinal events, at least using currently available techniques.

Entities:  

Mesh:

Year:  1987        PMID: 3557187      PMCID: PMC1432969          DOI: 10.1136/gut.28.2.146

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  18 in total

1.  MOTILITY OF THE PELVIC COLON. IV. ABDOMINAL PAIN ASSOCIATED WITH COLONIC HYPERMOTILITY AFTER MEALS.

Authors:  A M CONNELL; F A JONES; E N ROWLANDS
Journal:  Gut       Date:  1965-04       Impact factor: 23.059

Review 2.  The irritable bowel.

Authors:  W G Thompson
Journal:  Gut       Date:  1984-03       Impact factor: 23.059

3.  Comparison of rectosigmoid myoelectrical activity in the irritable colon syndrome during relapses and remissions.

Authors:  I Taylor; C Darby; P Hammond
Journal:  Gut       Date:  1978-10       Impact factor: 23.059

4.  Variability of colonic function in healthy subjects.

Authors:  J B Wyman; K W Heaton; A P Manning; A C Wicks
Journal:  Gut       Date:  1978-02       Impact factor: 23.059

5.  Dietary intakes and stool characteristics of patients with the irritable bowel syndrome.

Authors:  L C Hillman; N H Stace; A Fisher; E W Pomare
Journal:  Am J Clin Nutr       Date:  1982-10       Impact factor: 7.045

6.  Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome.

Authors:  J Ritchie
Journal:  Gut       Date:  1973-02       Impact factor: 23.059

7.  Irritable bowel syndrome: relationship of disorders in the transit of a single solid meal to symptom patterns.

Authors:  P A Cann; N W Read; C Brown; N Hobson; C D Holdsworth
Journal:  Gut       Date:  1983-05       Impact factor: 23.059

8.  Irritable bowel patients and their long-term response to a high fiber diet.

Authors:  L C Hillman; N H Stace; E W Pomare
Journal:  Am J Gastroenterol       Date:  1984-01       Impact factor: 10.864

9.  What is the benefit of coarse wheat bran in patients with irritable bowel syndrome?

Authors:  P A Cann; N W Read; C D Holdsworth
Journal:  Gut       Date:  1984-02       Impact factor: 23.059

10.  Functional abdominal pain: further evidence that whole gut is affected.

Authors:  K J Moriarty; A M Dawson
Journal:  Br Med J (Clin Res Ed)       Date:  1982-06-05
View more
  5 in total

1.  Symptoms of IBS and objective measurements of large bowel function.

Authors:  G Lamont; D Evans; J Reynolds
Journal:  Gut       Date:  1987-10       Impact factor: 23.059

2.  Longterm treatment of irritable bowel syndrome with cimetropium bromide: a double blind placebo controlled clinical trial.

Authors:  G Dobrilla; B P Imbimbo; L Piazzi; G Bensi
Journal:  Gut       Date:  1990-03       Impact factor: 23.059

3.  Intestinal transit in anxiety and depression.

Authors:  D A Gorard; J E Gomborone; G W Libby; M J Farthing
Journal:  Gut       Date:  1996-10       Impact factor: 23.059

4.  Evidence for the ambiguity of the term constipation: the role of irritable bowel syndrome.

Authors:  C S Probert; P M Emmett; H A Cripps; K W Heaton
Journal:  Gut       Date:  1994-10       Impact factor: 23.059

5.  How bad are the symptoms and bowel dysfunction of patients with the irritable bowel syndrome? A prospective, controlled study with emphasis on stool form.

Authors:  K W Heaton; S Ghosh; F E Braddon
Journal:  Gut       Date:  1991-01       Impact factor: 23.059

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.